Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.79 |
| ▸ | PTPRC | P08575 | 1/20 | 0.62 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.57 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9674046 | 0.95 | CES1 (0.71) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL29915354 | 0.95 | CES1 (0.71) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL9673279 | 0.88 | CES1 (0.89) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL30448645 | 0.88 | CES1 (1.00) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL12288017 | 0.86 | CES1 (0.60) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL7318972 | 0.83 | CES1 (0.70) | CES1PTPRCPABPC1DNMT1 | |
| SCHEMBL9672453 | 0.81 | CES1 (0.67) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL16258036 | 0.79 | CES1 (0.52) | CES1PTPRCPABPC1DNMT1 | |
| SCHEMBL29339224 | 0.79 | CES1 (0.52) | CES1PTPRCPABPC1DNMT1PTGS2 | |
| SCHEMBL6001685 | 0.78 | MAOA (0.68) | CES1PTPRCPABPC1DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188101-A1 | TIN-CONTAINING ASYMMETRIC DONOR MATERIAL AND PREPARATION METHOD AND USE THEREOF | JIANGHAN UNIVERSITY (CN) | 2025-06-12 | — | — | US | claimed |
| CN-117430621-B | A-D-A indacenodithiophene planar conjugated derivative and preparation method and application thereof | 福建农林大学 | 2025-06-10 | — | — | CN | claimed |
| CN-119528967-A | Asymmetric donor material containing tin atom and preparation method and application thereof | 江汉大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118440591-B | Nano silver ion conductive coating material and preparation method thereof | 东立信技术(青岛)有限公司 | 2025-01-21 | — | — | CN | claimed |
| US-20240405203-A1 | AQUEOUS ELECTROCHEMICAL CELLS AND COMPONENTS THEREFOR | ALSYM ENERGY INC (US) | 2024-12-05 | — | — | US | claimed |
| WO-2024243195-A1 | AQUEOUS ELECTROCHEMICAL CELLS AND COMPONENTS THEREFOR | Alsym Energy, Inc. (US) | 2024-11-28 | — | — | WO | claimed |
| CN-118888340-A | Use of redox couples in lithium-air capacitor cells of single electrolyte double cathode construction | 中山大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118771540-A | Molecularly imprinted polymer electrocatalytic polar plate and preparation method and application thereof | 南京大学 | 2024-10-15 | — | — | CN | claimed |
| CN-118619966-A | Selenyl side chain small molecule electron donor material and preparation method and application thereof | 中国科学院重庆绿色智能技术研究院 | 2024-09-10 | — | — | CN | claimed |
| CN-118598885-A | Side chain modified benzodithiophene small molecule donor material and preparation method and application thereof | 青岛大学 | 2024-09-06 | — | — | CN | claimed |
| CN-117820332-B | Benzothiophene-thiourea compound and preparation method and application thereof | 烟台大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117820332-A | Benzothiophene-thiourea compound and preparation method and application thereof | 烟台大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117430621-A | A-D-A indacenodithiophene planar conjugated derivative and preparation method and application thereof | 福建农林大学 | 2024-01-23 | — | — | CN | claimed |
| CN-117105348-A | Electrocatalytic polar plate and preparation method and application thereof | 南京大学 | 2023-11-24 | — | — | CN | claimed |
| CN-112599789-B | Double-cathode structure and lithium-oxygen battery manufactured by using same | 河南大学 | 2022-03-08 | — | — | CN | claimed |
| US-20190300554-A1 | NOVEL DITHIOPHENE COMPOUND, PREPARATION AND ITS APPLICATION IN ORGANIC PHOTOVOLTAICS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2019-10-03 | — | — | US | claimed |
| WO-2018069935-A1 | NOVEL DITHIOPHENE COMPOUND, PREPARATION AND ITS APPLICATION IN ORGANIC PHOTOVOLTAICS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-04-19 | — | — | WO | claimed |
| US-20090314997-A1 | SUBSTITUTED BENZODITHIOPHENES AND BENZODISELENOPHENES | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-24 | — | — | US | claimed |
| EP-2044082-A1 | SUBSTITUTED BENZODITHIOPHENES AND BENZODISELENOPHENES | Merck Patent GmbH (DE) | 2009-04-08 | — | — | EP | claimed |
| WO-2008011957-A1 | SUBSTITUTED BENZODITHIOPHENES AND BENZODISELENOPHENES | MERCK PATENT GMBH (DE) | 2008-01-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090314997-A1 | SUBSTITUTED BENZODITHIOPHENES AND BENZODISELENOPHENES | TPST2, TST, XPOT | CES1 4573/4885PTPRC 3788/4885PABPC1 2392/4885 |
| US-20250188101-A1 | TIN-CONTAINING ASYMMETRIC DONOR MATERIAL AND PREPARATION METHOD AND USE THEREOF | SLC7A5, LSM8, CDK8 | CES1 4753/4885PTPRC 1632/4885PABPC1 4099/4885 |
| US-20190300554-A1 | NOVEL DITHIOPHENE COMPOUND, PREPARATION AND ITS APPLICATION IN ORGANIC PHOTOVOLTAICS THEREOF | DDT, TST, DIMT1 | CES1 4786/4885PTPRC 2453/4885PABPC1 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.